astraZeneca

AstraZeneca COVID-19 vaccine trial on hold after adverse patient reaction

The report said suspension of the trial was having an impact on other AstraZeneca vaccine trials - as well as on clinical trials being conducted by other vaccine makers.

By REUTERS
09/09/2020
Emergent signs deal to make British COVID-19 vaccine

AstraZeneca in June picked Emergent to help produce 300 million doses of its potential COVID-19 vaccine pledged to the United States.

By REUTERS
27/07/2020
AstraZeneca signs $6 bln cancer drug deal with Daiichi

The London-listed company said on Monday it would pay Daiichi an upfront payment of $1 billion for DS-1062, a type of antibody drug conjugate (ADC).

By REUTERS
27/07/2020
Moderna, Merck will not limit price of COVID-19 vaccines to company cost

Executives from Johnson & Johnson and AstraZeneca testified that they will price their respective potential vaccines at no profit while the pandemic rages on.

By REUTERS
22/07/2020
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use